dr. arend on novel combination strategies in gynecologic cancer
Published 6 years ago • 48 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:18
dr. arend on the rationale of novel combinations in gynecologic cancer
-
3:22
novel combination strategies in recurrent ovarian cancer
-
1:02
dr. wingo on advances of surgical technology in gynecologic cancers
-
1:14
dr. arend on niraparib with bevacizumab in ovarian cancer
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
2:57
ovarian cancer: warning signs you should notice
-
20:48
ovarian cancer patient | sara's story: how i got diagnosed & treatment decisions (video 1/3)
-
21:29
my ovarian cancer story at age 22 during covid-19
-
1:19
dr. markman on the role of molecular testing in gynecologic cancers
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
0:50
dr. arend on the portec-3 trial for endometrial cancer
-
1:00
dr. coleman on the role of ramucirumab in gynecologic cancer
-
36:20
gynecologic cancer immunotherapy: new potential in gynecologic cancers
-
1:11:05
ahead of cancer | updates in the diagnosis & treatment of gynecologic cancer | ahn
-
1:12
dr. arend discusses targets in endometrial cancer
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
8:29
emerging combinations in the frontline setting of ovarian cancer
-
13:58
novel therapies and combinations in ovarian cancer
-
1:08
dr. o’malley on the state of immunotherapy in ovarian cancer
-
20:24
dr. john chan, gynecologic oncologist
-
1:02
dr. wenham on rationale for novel immunotherapy combos in ovarian cancer
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer